These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33689536)

  • 1. Survival impact of incidental subventricular zone irradiation in IDH-wildtype glioblastoma.
    Hallaert G; Pinson H; Van den Broecke C; Sweldens C; Van Roost D; Kalala JP; Boterberg T
    Acta Oncol; 2021 May; 60(5):613-619. PubMed ID: 33689536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection.
    Chen L; Guerrero-Cazares H; Ye X; Ford E; McNutt T; Kleinberg L; Lim M; Chaichana K; Quinones-Hinojosa A; Redmond K
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):616-22. PubMed ID: 23540348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between survival and increased radiation dose to subventricular zone in glioblastoma is controversial.
    Elicin O; Inac E; Uzel EK; Karacam S; Uzel OE
    J Neurooncol; 2014 Jun; 118(2):413-419. PubMed ID: 24668610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of subventricular zone irradiation on outcome of patients with glioblastoma.
    Mathew BS; Kaliyath SB; Krishnan J; Bhasi S
    J Cancer Res Ther; 2018; 14(6):1202-1206. PubMed ID: 30488830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subventricular zones: new key targets for glioblastoma treatment.
    Khalifa J; Tensaouti F; Lusque A; Plas B; Lotterie JA; Benouaich-Amiel A; Uro-Coste E; Lubrano V; Cohen-Jonathan Moyal E
    Radiat Oncol; 2017 Apr; 12(1):67. PubMed ID: 28424082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the role of the subventricular zone in radiotherapy of glioblastoma patients?
    Bender K; Träger M; Wahner H; Onken J; Scheel M; Beck M; Ehret F; Budach V; Kaul D
    Radiother Oncol; 2021 May; 158():138-145. PubMed ID: 33636228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis.
    Lee P; Eppinga W; Lagerwaard F; Cloughesy T; Slotman B; Nghiemphu PL; Wang PC; Kupelian P; Agazaryan N; Demarco J; Selch MT; Steinberg M; Kang JJ
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):609-15. PubMed ID: 23462418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicogenetic characteristics and the effect of radiation on the neural stem cell niche in subventricular zone-contacting glioblastoma.
    Kahng JY; Kang BH; Lee ST; Choi SH; Kim TM; Park CK; Won JK; Park SH; Son J; Lee JH
    Radiother Oncol; 2023 Sep; 186():109800. PubMed ID: 37423479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-based survival differences in IDH-wildtype glioblastoma: Results from a retrospective cohort study.
    Hallaert G; Pinson H; Van den Broecke C; Van Roost D; Kalala JP; Boterberg T
    J Clin Neurosci; 2021 Sep; 91():209-213. PubMed ID: 34373029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide.
    Berger K; Turowski B; Felsberg J; Malzkorn B; Reifenberger G; Steiger HJ; Budach W; Haussmann J; Knipps J; Rapp M; Hänggi D; Sabel M; Mijderwijk HJ; Kamp MA
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):253-262. PubMed ID: 32748120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR Imaging, MGMT Promoter Methylation Features and Prognostic Analysis of Subventricular Zone Contacting IDH Wild-type Glioblastoma.
    Liu R; Liu Q; Zhao K; Liu M; Sun G; Xu B
    Curr Med Imaging; 2023; 19(12):1378-1386. PubMed ID: 36694322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of incidental radiation dose in the subventricular zone on survival in patients with glioblastoma multiforme treated with surgery, radiotherapy, and temozolomide.
    Foro Arnalot P; Pera O; Rodriguez N; Sanz X; Reig A; Membrive I; Ortiz A; Granados R; Algara M
    Clin Transl Oncol; 2017 Oct; 19(10):1225-1231. PubMed ID: 28389881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of MGMT promoter methylation on the survival of TMZ treated
    Chai R; Li G; Liu Y; Zhang K; Zhao Z; Wu F; Chang Y; Pang B; Li J; Li Y; Jiang T; Wang Y
    Cancer Biol Med; 2021 Feb; 18(1):272-282. PubMed ID: 33628600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subventricular zone contacting glioblastoma: tumor size, molecular biological factors and patient survival.
    Hallaert G; Pinson H; Van den Broecke C; Vanhauwaert D; Van Roost D; Boterberg T; Kalala JP
    Acta Oncol; 2020 Dec; 59(12):1474-1479. PubMed ID: 32672481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of wide opening of the lateral ventricle on survival for supratentorial glioblastoma patients with radiotherapy and concomitant temozolomide-based chemotherapy.
    Saito T; Muragaki Y; Maruyama T; Komori T; Nitta M; Tsuzuki S; Fukui A; Kawamata T
    Neurosurg Rev; 2020 Dec; 43(6):1583-1593. PubMed ID: 31705405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subventricular zone volumetric and dosimetric changes during postoperative brain tumor irradiation and its impact on overall survival.
    Darázs B; Ruskó L; Végváry Z; Ferenczi L; Dobi Á; Paczona V; Varga Z; Fodor E; Hideghéty K
    Phys Med; 2019 Dec; 68():35-40. PubMed ID: 31733404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of glioblastoma contact with the subventricular zone on survival and recurrence patterns.
    Comas S; Luguera E; Molero J; Balaña C; Estival A; Castañer S; Carrato C; Hostalot C; Teixidor P; Villà S
    Clin Transl Oncol; 2021 Mar; 23(3):554-564. PubMed ID: 32728970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy.
    Li H; Li J; Cheng G; Zhang J; Li X
    Clin Neurol Neurosurg; 2016 Dec; 151():31-36. PubMed ID: 27764705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low MGMT digital expression is associated with a better outcome of IDH1 wildtype glioblastomas treated with temozolomide.
    Gomes I; Moreno DA; Dos Reis MB; da Silva LS; Leal LF; Gonçalves GM; Pereira CA; Oliveira MA; de Medeiros Matsushita M; Reis RM
    J Neurooncol; 2021 Jan; 151(2):135-144. PubMed ID: 33400009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.